Shire Announces European Approval of Manufacturing Facility for VPRIV

Shire plc SHPGY announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has approved the production of VPRIV® (velaglucerase alfa) in its new state-of-the-art manufacturing facility at 400 Shire Way in Lexington, MA. The European Commission's decision is expected imminently.